Search peptides, terms, sources/

Mitochondrial Research

Mitochondrial research covers peptides studied for effects on mitochondrial function, including rare inherited mitochondrial diseases. The evidence ranges from cell and animal work to small human trials in ultra-rare conditions and one large phase 3 trial that did not meet its main endpoints. A peptide's presence here reflects a documented line of mitochondrial research, not a demonstrated benefit.

Which peptides have been studied in mitochondrial research?

  • Elamipretide

    Synthetic four-amino-acid peptide studied in rare mitochondrial diseases. US accelerated approval for Barth syndrome; not authorised in the UK. A large phase 3 trial failed.

    Immune and longevityHuman trialsEvidence reviewed
    PreliminaryNot licensed in the UK

View in the full index

Best recorded finding for each peptide in this area

The best recorded finding for each peptide in this area. Each row grades one finding, not the peptide or the medicine.
PeptideUK statusFindingStudy typeEvidence grade
ElamipretideNot licensed in the UKBarth syndrome, 168-week extensionHuman trialPreliminary

"Mitochondrial Research" groups peptides studied for effects on mitochondrial function, including rare inherited mitochondrial diseases. Evidence in this category ranges from cell and animal work to small human trials in ultra-rare conditions and one large phase 3 trial that did not meet its endpoints. Inclusion reflects a documented line of mitochondrial research, not a demonstrated benefit.

0 sources in the library relate to this area. See them.

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.